Malignancy Rates in Brodalumab Clinical Studies for Psoriasis

Gottlieb, A; Lebwohl, M; Liu, C; Israel, RJ; Jacobson, A

Gottlieb, A (corresponding author), Icahn Sch Med Mt Sinai, 10 Union Sq East, New York, NY 10003 USA.

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2020; 21 (3): 421

Abstract

Background Brodalumab is a fully human anti-interleukin-17 receptor A monoclonal antibody efficacious for the treatment of adults with moderate-to-sev......

Full Text Link